Their cashflow would support a lot of debt (if they wanted) but not enough for BTA (I think)
Market cap of BTA about $360 million (probably would need twice that).
I would have thought an acquisition could expand their prescence in their own distribution channel, namely oncology and hospital as opposed to primary care.
Their cashflow would support a lot of debt (if they wanted) but...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 17.5¢ | 17.5¢ | $19.81K | 113.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 6422505 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 1547308 | 16 |
View Market Depth
| Last trade - 15.58pm 30/07/2024 (20 minute delay) ? |
| SRX (ASX) Chart |